Showing results (41-50 of 120) with videos related to
Sort By:
Pageof 12
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2012
The orally active glutamate carboxypeptidase II inhibitor E2072 exhibits sustained nerve exposure and attenuates peripheral neuropathyKrystyna M Wozniak, Ying Wu, James J Vornov, et al.Peerj|October 4, 2019
A comparison of inducible, ontogenetic, and interspecific sources of variation in the foliar metabolome in tropical treesBrian E Sedio, Armando Durant Archibold, Juan Camilo Rojas Echeverri, et al.Journal of Medicinal Chemistry|August 17, 2016
Optimizing Protonation States for Selective Double-Strand DNA Photocleavage in Hypoxic Tumors: pH-Gated Transitions of Lysine DipeptidesKemal Kaya, Saumya Roy, Juan Carlos Nogues, et al.Journal of Neurovirology|February 4, 2015
Neurological sequelae induced by alphavirus infection of the CNS are attenuated by treatment with the glutamine antagonist 6-diazo-5-oxo-l-norleucineMichelle C Potter, Victoria K Baxter, Robert W Mathey, et al.Current Topics in Medicinal Chemistry|March 14, 2007
Azetidine-based inhibitors of dipeptidyl peptidase IV (DPP IV)Dana Ferraris, Sergei Belyakov, Weixing Li, et al.Bioorganic & Medicinal Chemistry Letters|June 12, 2003
Synthesis and biological evaluation of hydroxamate-Based inhibitors of glutamate carboxypeptidase IIDoris Stoermer, Qun Liu, Monicia R Hall, et al.Neurobiology of Disease|June 22, 2016
Maternal inflammation leads to impaired glutamate homeostasis and up-regulation of glutamate carboxypeptidase II in activated microglia in the fetal/newborn rabbit brainZhi Zhang, Bassam Bassam, Ajit G Thomas, et al.Journal of Biomolecular Screening|July 4, 2012
Development of a high-throughput fluorescence polarization assay to identify novel ligands of glutamate carboxypeptidase IIGlenda Alquicer, David Sedlák, Youngjoo Byun, et al.Plos One|July 8, 2015
Selective CNS Uptake of the GCP-II Inhibitor 2-PMPA following Intranasal AdministrationRana Rais, Krystyna Wozniak, Ying Wu, et al.European Journal of Pharmacology|October 20, 2009
Palonosetron triggers 5-HT(3) receptor internalization and causes prolonged inhibition of receptor functionCamilo Rojas, Ajit G Thomas, Jesse Alt, et al.Pageof 12